Matthew Martz, PhD¶
Matthew Martz, PhD
Executive leader building and scaling global AI/ML organizations that deliver measurable business value. Expert in directing 25+ member teams including senior management across 10 countries, with proven success driving 100x growth through production AI platforms at Fortune 500 companies and high-growth startups.
April 2026 — New Role
Joined Gifthealth as Director of AI Engineering — leading the development and scaling of the AI foundations, capabilities, and engineering at a PE-backed digital pharmacy platform serving millions of patients nationwide. Read more about my current work →
Mission & Vision¶
My collective experience in advanced AI, sophisticated knowledge graph development, and multimodal modeling is strategically directed towards a pioneering vision: building AI platforms that model complex systems at scale—enabling organizations to predict, optimize, and transform outcomes across consumer AI, biotechnology, agriculture, and healthcare.
I am passionate about accelerating the research-to-value timeline—transforming cutting-edge AI research into production systems that deliver measurable business impact. My unique strength lies at the intersection of deep innovation and pragmatic execution: I drive rapid translation of theoretical breakthroughs into operational systems that unlock new value channels across industries, delivering future-state capabilities today through proven track record of 100x growth, $M+ revenue, and sustained competitive advantage.
🚀 Featured Platform: Loom¶
Loom: Healthcare AI Platform for Precision Medicine
Transforming 2.3M+ patient records into actionable insights through knowledge graphs and digital twins. Leading the future of precision medicine with AI-powered clinical decision support.
Executive Leadership & Strategic Vision¶
I bring 22 years of engineering experience with 18+ years building and leading production AI/ML platforms and high-performing data science organizations across startups, Fortune 500 companies, and international corporations. This progression has culminated in executive leadership directing 25+ member globally distributed teams including senior management spanning 10 countries, with full responsibility for AI/ML pipelines delivering measurable business value. I have a proven track record of building organizations from zero—growing teams and establishing complete AI capabilities spanning internal experimentation through external-facing production systems that drive 100x growth in consumer bases and profitability.
While deeply technical and capable of hands-on contribution when needed, my core strength is building and leading high-functioning organizations that transform cutting-edge AI innovation into production systems, revenue-generating products, and sustainable competitive advantage. I excel at navigating the intersection of technical innovation, business strategy, and organizational development—whether directing corporate AI initiatives at enterprise scale, driving startup growth as SVP/C-suite executive, or leading multi-million dollar programs with cross-functional stakeholder alignment from C-suite to board level.
18+ Years
Building Production AI at Scale & Executive Leadership
25+ Members
Including Senior Management
10 Countries
Global Program Leadership
100x Growth
Consumer Base & Profitability
$M+ Budget
Full P&L & Pipeline Control
0 to Scale
Built Complete AI Organizations
Executive Leadership: Deep Technical Innovation to Strategic Execution¶
I lead teams advancing novel research to production execution across the full AI/ML technology stack, driving industry-changing innovations like AdaptQ (Activation-Driven Adaptive Pathway Tuning with Quantization)—my breakthrough algorithm family that eliminates catastrophic forgetting in large language model fine-tuning. As a deeply technical executive, I personally architect the mathematical foundations and algorithmic innovations detailed here—from deriving novel optimization approaches to establishing information-theoretic constraints to designing neural architecture modifications—while building organizations that scale these breakthroughs to production. While my teams deliver comprehensive AI capabilities spanning machine learning, data engineering, and platform development, the innovations detailed here represent proprietary differentiation—solving fundamental problems that existing frameworks and commercial solutions cannot address. As both inventor and leader, I'm unlocking deployment in high-divergence domains (finance, medicine, legal, scientific research) where off-the-shelf approaches fail, addressing $180B+ in previously inaccessible markets.
I'm directing teams executing across five strategic innovation areas—proprietary approaches that go beyond standard AI capabilities—translating breakthrough research into production-ready enterprise solutions:
Five Strategic Innovation Areas — Proprietary approaches spanning compositional adaptation, rare event learning, adversarial robustness, knowledge graph-guided fine-tuning, and continual learning with regulatory checkpoints.
1. Compositional Adaptation Strategies Developing modular neuron cluster architectures that enable multiple specialized adaptations to coexist within a single model without interference. This approach allows organizations to compose independently updatable functional modules—such as regulatory compliance layers, domain expertise modules, and institution-specific protocols—within a unified system. By leveraging AdaptQ's neuron-level targeting capabilities, these modules can be activated contextually based on input requirements and updated independently without requiring complete model retraining. The architecture ensures that updates to one module (such as evolving compliance requirements) don't disrupt the performance or accuracy of other functional modules (like clinical decision support or institutional workflows). Organizations in high-divergence domains can maintain compliance, domain expertise, and operational customization simultaneously while dramatically reducing deployment complexity and update costs.
2. Active Learning for Rare Events Addressing the critical challenge of preserving rare event detection capabilities in long-tail distributions during model adaptation. In high-divergence domains, maintaining sensitivity to infrequent but high-consequence patterns—such as adverse drug interactions in medicine, emerging fraud patterns in finance, or novel legal precedents—is essential for system reliability and safety. Standard adaptation approaches often optimize for common cases while inadvertently degrading performance on statistically rare but critically important scenarios. This work develops techniques that ensure adaptive fine-tuning enhances domain performance on frequent cases while actively preserving or improving detection capabilities for rare events, using targeted activation analysis to identify and protect neurons critical for edge case recognition. This enables safe deployment of adapted AI systems in scenarios where failure to detect rare but critical events carries significant consequences for both organizations and end users.
3. Adversarial Robustness in Adaptation Investigating security implications of parameter-efficient fine-tuning to ensure adapted models don't introduce new attack surfaces or vulnerabilities during the specialization process. As AI systems enter production in high-divergence, high-stakes domains, understanding and mitigating adversarial risks introduced during adaptation becomes critical for maintaining system integrity. This work develops frameworks for secure adaptation that analyze how neuron-level modifications affect model robustness, identify potential vulnerability patterns introduced during fine-tuning, and establish validation protocols to ensure that domain specialization strengthens rather than compromises adversarial resilience. The approach combines activation-driven analysis with adversarial testing to create adaptation pathways that enhance domain capabilities while maintaining or improving resistance to adversarial attacks. Organizations gain confidence that domain adaptation strengthens rather than compromises system security, enabling deployment in security-sensitive environments.
4. Knowledge Graph-Guided Fine-Tuning Integrating structured knowledge representations to guide neuron targeting during model adaptation, enabling more precise and interpretable specialization. By leveraging domain ontologies, knowledge graphs, and established structural relationships, this approach aligns adaptation processes with validated domain knowledge rather than relying solely on statistical patterns in training data. The methodology uses knowledge graph structures to identify semantically meaningful neuron clusters, guide activation profiling toward conceptually coherent adaptations, and ensure that model modifications respect domain-specific relationships and constraints documented in formal knowledge structures. This combines deep expertise in knowledge graph architectures with advanced fine-tuning methodologies to create next-generation AI solutions that respect and incorporate domain structure while maintaining transparency about how adaptations relate to established knowledge. The result delivers interpretable, auditable adaptation processes that align with domain expertise—critical for regulatory compliance, building stakeholder trust in high-divergence domains, and enabling subject matter experts to validate that AI systems incorporate domain knowledge correctly.
5. Continual Learning with Regulatory Checkpoints Developing frameworks that allow models to adapt to evolving requirements—updated clinical guidelines, changing regulations, emerging best practices, new compliance standards—while maintaining validated performance on previously certified capabilities. This addresses the operational challenge of keeping AI systems current in dynamic regulatory environments without requiring expensive, time-consuming complete re-validation cycles. The approach establishes formal checkpoint mechanisms that partition model capabilities into validated modules, tracks which neurons and pathways contribute to certified performance on specific requirements, and enables targeted updates that modify uncertified portions while preserving certified functionality. By combining AdaptQ's neuron-level targeting with regulatory validation frameworks, organizations can adapt systems to new requirements while providing auditable evidence that previously validated capabilities remain intact and compliant. This reduces time-to-deployment for updates from months to days while maintaining compliance, enabling organizations to respond rapidly to regulatory changes and emerging requirements without sacrificing the validation investments already made.
Core Technical Approaches — These innovation areas leverage knowledge graph architectures, neuron-level activation analysis, mixed-precision optimization, and production-scale AI deployment across complex, regulated high-divergence domains.
Explore Core AdaptQ Innovation Below ↓ or view full technical foundations and mathematical framework on the Research Focus page.
Current Research Focus¶
AdaptQ — My algorithm family that eliminates catastrophic forgetting in LLM fine-tuning for high-divergence domains (medicine, law, finance), achieving 34-967× better knowledge preservation than LoRA with 37.5% memory savings.
Latest Research: AdaptQ - Solving Catastrophic Forgetting in High-Divergence Domains¶
I've created the AdaptQ family of algorithms to address a critical problem in AI: catastrophic forgetting in low-rank parameter-efficient fine-tuning (PEFT) for high-divergence domains like medicine, law, finance, and scientific research. These domains are particularly challenging because their specialized vocabularies and knowledge structures diverge significantly from general pretraining data, making it extremely difficult to tune models while maintaining general knowledge. Unfortunately, these same high-divergence domains are among the most important for AI in society—representing critical areas where innovation in AI technologies can substantially benefit humanity through improved healthcare, legal access, financial services, and scientific discovery.
When AI models are adapted to these high-divergence domains, they traditionally lose their general knowledge—a dangerous trade-off in high-stakes applications where both domain expertise and broad reasoning capabilities are essential.
The Problem: Low-Rank Adaptation (LoRA), the dominant method for fine-tuning large language models, exhibits catastrophic forgetting at production scales. Beyond 100-150 training samples, general knowledge degradation becomes severe, reaching +3,671% at 5,000 samples and +17,768% at 50,000 samples.
The Solution - ADAPT-Q:
- Activation-Driven Adaptive Pathway Tuning with Quantization
- Eliminates catastrophic forgetting through three core innovations:
- Activation-driven layer selection - Identifies domain-relevant pathways based on empirical activation patterns
- Full-precision selective adaptation - Removes the low-rank bottleneck by adapting selected layers without rank constraints
- Mixed-precision architecture - Combines 4-bit quantized frozen layers with FP16 adapted layers
Key Results:
- 34-967Ă— better general knowledge preservation compared to LoRA
- <5% degradation at all scales (vs LoRA's +17,768% at 50K samples)
- 37.5% memory savings while maintaining full performance
- Scale-independent stability - No catastrophic forgetting regardless of training data size
- Validated across legal, financial, and medical high-divergence domains
Impact: AdaptQ enables safe deployment of AI in high-divergence domains like healthcare, legal tech, financial services, and scientific research—areas where both domain expertise and general reasoning capabilities are critical for societal benefit. This solves the "impossible trinity" of compression + tuning + preservation that has limited production AI deployment in these crucial high-stakes domains.
Publication Status
Manuscripts in preparation/submission — Full research details including mathematical foundations available on Research Focus page — Paper links and adaptq.mutaku.io site coming soon
Read Full AdaptQ Research & Technical Details →
Healthcare AI Platform Innovation — Pioneering comprehensive healthcare AI platforms integrating knowledge graphs, federated learning, and digital twins to unlock precision medicine at population scale from healthcare's massively underutilized data.
I'm pioneering comprehensive healthcare AI platforms with the goal of defining a new future state for precision medicine—driven by innovations in AI and novel data methodologies like knowledge graphs—unlocking the largest untapped opportunity in modern medicine: billions of patient interactions and outcomes locked in fragmented systems. As architect of this technical vision, I personally designed the mathematical frameworks and algorithmic approaches that transform how AI captures complex relational patterns in healthcare data, then lead globally distributed teams executing from research breakthrough to production deployment.
The Challenge Being Solved: Less than 3% of healthcare's 2.5 exabytes of daily data is used for predictive analytics12, representing massive underutilization that could revolutionize patient care. Healthcare data is doubling every 73 days3, yet current AI approaches fail to capture the complex relational patterns essential for precision medicine45. My work establishes a new technical path—integrating graph-based architectures, federated learning, and digital twin technology—to fundamentally reimagine how AI serves clinical decision-making.
What I've Led Teams to Build:
- 2.3 million patient knowledge graph demonstrating scalable AI platform capabilities I architected, leveraging graph neural networks that have shown 15-30% accuracy improvements over traditional approaches67
- Privacy-preserving federated learning infrastructure I designed enabling multi-site collaboration without data sharing, addressing the critical barrier where 73% of healthcare organizations cite data silos as a major impediment89
- Clinical workflow integration with 15+ interfaces and 100+ service methods my teams developed, designed to overcome the <15% adoption rate typical of AI clinical decision support tools10
- Patient digital twins for precision medicine at population scale, implementing this vision aligned with emerging research on digital twin technology in healthcare111213
Advancing Precision Care: I'm personally advancing the algorithmic foundations that integrate clinical, genomic, and pathway data to create comprehensive patient digital twins for transformative clinical impact—from deriving novel graph-based optimization approaches to establishing federated learning protocols that preserve privacy while enabling collaborative model training. This work combines my 18 years of production ML/AI experience with deep clinical domain expertise, grounded in the National Academy of Medicine's vision for continuously learning health systems1415. Leading teams executing this roadmap, we're building platforms that fundamentally transform how precision medicine is delivered at population scale.
Learn More About My Healthcare AI Research →
Executive Technical Leadership & Deep Innovation¶
Executive Leadership at Scale
Novel Innovations I've Personally Architected
Distributed Systems & Optimization I've Architected With
Production Systems Built & Scaled
Latest News & Updates¶
Recent Highlight
April 2026 — Joined Gifthealth as Director of AI Engineering. Leading AI strategy and building out the AI foundations, capabilities, and engineering across pharmacy operations, CX, and healthcare workflows. More details →
Current Position¶
Director of AI Engineering
Connect With Me¶
Ready to discuss AI innovation, clinical applications, or potential collaborations?
References¶
-
Raghupathi, W., & Raghupathi, V. "Big data analytics in healthcare: promise and potential." Health Information Science and Systems, 2(1), 3, 2014. ↩
-
IBM Institute for Business Value. "The healthcare data explosion: Improving analytics to drive innovation." IBM Corporation, 2020. ↩
-
Dinov, I.D. "Volume and Value of Big Biomedical Data." Journal of Medical Statistics and Informatics, 4(1), 2016. ↩
-
Nicholson, D.N., & Greene, C.S. "Constructing knowledge graphs and their biomedical applications." Computational and Structural Biotechnology Journal, 18, 1414-1428, 2020. ↩
-
Mohamed, S.K., et al. "Biological applications of knowledge graph embedding models." Briefings in Bioinformatics, 22(2), 1679-1693, 2021. ↩
-
Li, X., et al. "Graph neural network-based diagnosis prediction." Big Data, 8(5), 379-390, 2020. ↩
-
Zhou, J., et al. "Graph neural networks: A review of methods and applications." AI Open, 1, 57-81, 2020. ↩
-
Healthcare Information and Management Systems Society (HIMSS). "2022 Healthcare Data Analytics Survey." HIMSS Analytics, 2022. ↩
-
Rieke, N., et al. "The future of digital health with federated learning." NPJ Digital Medicine, 3(1), 119, 2020. ↩
-
Sutton, R.T., et al. "An overview of clinical decision support systems: benefits, risks, and strategies for success." NPJ Digital Medicine, 3(1), 17, 2020. ↩
-
Venkatesh, K.P., et al. "Digital Twins for Health: Opportunities, Challenges, and Practical Implications." Nature Medicine, 28(11), 2188-2190, 2022. ↩
-
Laubenbacher, R., et al. "Using digital twins in viral infection." Science, 371(6534), 1105-1106, 2021. ↩
-
Corral-Acero, J., et al. "The 'Digital Twin' to enable the vision of precision cardiology." European Heart Journal, 41(48), 4556-4564, 2020. ↩
-
Institute of Medicine. "Best Care at Lower Cost: The Path to Continuously Learning Health Care in America." The National Academies Press, 2013. ↩
-
Friedman, C.P., et al. "Toward a science of learning systems: a research agenda for the high-functioning Learning Health System." Journal of the American Medical Informatics Association, 22(1), 43-50, 2015. ↩
-
McKinsey & Company. "Transforming healthcare with AI: The impact on the workforce and organizations." McKinsey Global Institute, 2020. ↩
-
Davenport, T., & Kalakota, R. "The potential for artificial intelligence in healthcare." Future Healthcare Journal, 6(2), 94-98, 2019. ↩